ATE227978T1 - Orale flüssige mucoadhäsive zusammensetzungen - Google Patents
Orale flüssige mucoadhäsive zusammensetzungenInfo
- Publication number
- ATE227978T1 ATE227978T1 AT99942428T AT99942428T ATE227978T1 AT E227978 T1 ATE227978 T1 AT E227978T1 AT 99942428 T AT99942428 T AT 99942428T AT 99942428 T AT99942428 T AT 99942428T AT E227978 T1 ATE227978 T1 AT E227978T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- safe
- mixtures
- effective amount
- respiratory tract
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- 239000007788 liquid Substances 0.000 title abstract 2
- 230000003232 mucoadhesive effect Effects 0.000 title 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 206010057190 Respiratory tract infections Diseases 0.000 abstract 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 230000000954 anitussive effect Effects 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000003434 antitussive agent Substances 0.000 abstract 1
- 229940124584 antitussives Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000004927 clay Substances 0.000 abstract 1
- 229910052570 clay Inorganic materials 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000000850 decongestant Substances 0.000 abstract 1
- 229940124581 decongestants Drugs 0.000 abstract 1
- 239000003172 expectorant agent Substances 0.000 abstract 1
- 230000003419 expectorant effect Effects 0.000 abstract 1
- 229940066493 expectorants Drugs 0.000 abstract 1
- 239000004083 gastrointestinal agent Substances 0.000 abstract 1
- 229940125695 gastrointestinal agent Drugs 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 210000002850 nasal mucosa Anatomy 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 abstract 1
- 238000004062 sedimentation Methods 0.000 abstract 1
- 230000001953 sensory effect Effects 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 239000004408 titanium dioxide Substances 0.000 abstract 1
- 230000001960 triggered effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Anesthesiology (AREA)
- Physiology (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Developing Agents For Electrophotography (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9764698P | 1998-08-24 | 1998-08-24 | |
| PCT/US1999/019201 WO2000010528A1 (en) | 1998-08-24 | 1999-08-24 | Oral liquid mucoadhesive compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE227978T1 true ATE227978T1 (de) | 2002-12-15 |
Family
ID=22264456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99942428T ATE227978T1 (de) | 1998-08-24 | 1999-08-24 | Orale flüssige mucoadhäsive zusammensetzungen |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20020009478A1 (de) |
| EP (1) | EP1107732B1 (de) |
| JP (1) | JP2002523353A (de) |
| KR (1) | KR20010074834A (de) |
| CN (1) | CN1313754A (de) |
| AT (1) | ATE227978T1 (de) |
| AU (1) | AU753251B2 (de) |
| BR (1) | BR9913148A (de) |
| CA (1) | CA2338480C (de) |
| CO (1) | CO5140074A1 (de) |
| DE (1) | DE69904057T2 (de) |
| DK (1) | DK1107732T3 (de) |
| ES (1) | ES2185395T3 (de) |
| HU (1) | HUP0103217A2 (de) |
| NO (1) | NO20010830D0 (de) |
| PE (1) | PE20000863A1 (de) |
| TR (1) | TR200100569T2 (de) |
| WO (1) | WO2000010528A1 (de) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020009478A1 (en) * | 1998-08-24 | 2002-01-24 | Douglas Joseph Dobrozsi | Oral liquid mucoadhesive compositions |
| EP1363600B1 (de) * | 2001-02-15 | 2008-10-01 | Access Pharmaceuticals, Inc. | Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen |
| US7544348B2 (en) * | 2001-02-15 | 2009-06-09 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| ES2195757B1 (es) * | 2001-12-28 | 2005-03-01 | Laboratorios Calier, S.A. | Procedimiento para combatir las infestaciones de las colmenas de abejas. |
| MXPA04010860A (es) * | 2002-05-02 | 2005-11-17 | Cragmont Pharmaceuticals Llc | Composiciones terapeuticas de 1,2,3,6-tetrahidropirimidin-2-ona y metodos para usarla. |
| US7947742B2 (en) * | 2002-06-28 | 2011-05-24 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
| US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
| US20050058672A1 (en) * | 2003-09-14 | 2005-03-17 | Bioderm Research | Baby Care Skin Protectant Compositions for Diaper Rash |
| DE10332486A1 (de) * | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung akuter Schmerzen |
| US7482378B2 (en) * | 2004-05-28 | 2009-01-27 | Millenium Specialty Chemicals, Inc. | Physiological cooling compositions |
| WO2006009825A1 (en) * | 2004-06-17 | 2006-01-26 | Virun, Inc. | Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents |
| PT2486942T (pt) | 2004-11-24 | 2019-01-18 | Meda Pharmaceuticals Inc | Composições que compreendem azelastina e seus métodos de utilização |
| US20060216359A1 (en) * | 2005-03-25 | 2006-09-28 | Lowell Riegel | Topical preparation for treating ulcerations on the inside of the month |
| TR200803299T1 (tr) * | 2005-11-10 | 2008-11-21 | Century Biologicals Private Limited | Solunum yolu rahatsızlıklarını tedavi etmek için kullanılan dengeli bir formülasyon. |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| FR2900824A1 (fr) * | 2006-05-10 | 2007-11-16 | Prod Dentaires Pierre Rolland | Pate destinee a arreter les saignements, ses utilisations, et seringue la contenant |
| WO2007140191A2 (en) | 2006-05-23 | 2007-12-06 | Theracos, Inc. | Glucose transport inhibitors and methods of use |
| US8748419B2 (en) | 2006-06-16 | 2014-06-10 | Theracos, Inc. | Treating obesity with muscarinic receptor M1 antagonists |
| US7893053B2 (en) | 2006-06-16 | 2011-02-22 | Theracos, Inc. | Treating psychological conditions using muscarinic receptor M1 antagonists |
| US20080003280A1 (en) * | 2006-06-26 | 2008-01-03 | Levine Brian M | Combination cough treatment compounds and method of treating common coughs |
| CN101138541B (zh) * | 2006-09-06 | 2010-10-06 | 上海医药工业研究院 | 氨来占诺局部成膜凝胶组合物及其应用 |
| ES2466672T3 (es) | 2007-04-02 | 2014-06-10 | Theracos, Inc. | Derivados de glicósido bencílico y métodos de uso |
| JP4809931B2 (ja) | 2007-08-23 | 2011-11-09 | セラコス・インコーポレイテッド | ベンジルベンゼン誘導体およびその使用方法 |
| US20090123570A1 (en) * | 2007-11-09 | 2009-05-14 | Warner W Randolph | Composition and method for treating sore throat |
| US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
| CA2704949A1 (en) | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
| US20090131386A1 (en) * | 2007-11-13 | 2009-05-21 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| US20090148530A1 (en) | 2007-12-08 | 2009-06-11 | Jamie Koufman | Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| MX2010011545A (es) | 2008-04-21 | 2011-04-11 | Otonomy Inc | Formulaciones para tratar enfermedades y afecciones del oido. |
| US20090264392A1 (en) * | 2008-04-21 | 2009-10-22 | Meritage Pharma, Inc. | Treating eosinophilic esophagitis |
| MX2011000637A (es) | 2008-07-15 | 2011-05-02 | Theracos Inc | Derivados deuretados de bencilbenceno y metodos de uso. |
| US8784870B2 (en) * | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
| EP2306975A4 (de) | 2008-07-21 | 2012-10-31 | Otonomy Inc | Zusammensetzungen mit gesteuerter freisetzung zur modulierung der ohrenstruktur und des angeborenen immunsystems sowie verfahren zur behandlung von ohrerkrankungen |
| DK2328553T3 (da) | 2008-08-20 | 2020-08-24 | Univ California | Corticosteroider til behandling af inflammatoriske sygdomme i mave-tarm-kanalen |
| EP2324002B1 (de) | 2008-08-22 | 2016-10-05 | Theracos Sub, LLC | Verfahren zur herstellung von sglt2-hemmern |
| US7914828B2 (en) * | 2008-10-17 | 2011-03-29 | Levine Brian M | Combination herbal product to benefit respiratory tract |
| JP5930278B2 (ja) | 2008-11-25 | 2016-06-08 | ユニバーシティー オブ ロチェスター | Ｍｌｋ阻害剤および使用方法 |
| GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
| CA2800176C (en) | 2010-05-24 | 2018-08-28 | University Of Rochester | Bicyclic heteroaryl kinase inhibitors and methods of use |
| WO2011153712A1 (en) | 2010-06-12 | 2011-12-15 | Theracos, Inc. | Crystalline form of benzylbenzene sglt2 inhibitor |
| US8361519B2 (en) | 2010-11-18 | 2013-01-29 | Aadvantics Pharmaceuticals, Inc. | Combination herbal product to benefit respiratory tract in people exposed to smoke |
| JP6133790B2 (ja) | 2011-02-18 | 2017-05-24 | ザ スクリプス リサーチ インスティテュート | ミエリン形成細胞運命へのオリゴデンドロサイト前駆細胞の定方向分化 |
| US8524664B2 (en) | 2011-06-02 | 2013-09-03 | Colorado Seminary, Which owns and Operates The Univeristy of Denver | Methods of treating overproduction of cortisol using ACTH antagonist peptides |
| ES2740958T5 (en) | 2012-02-27 | 2025-04-03 | Elanco New Zealand | Controlled release compositions and their methods of use |
| US20150133565A1 (en) * | 2012-06-15 | 2015-05-14 | University Of New Hampshire | Sustained release hydrogel-based stimulant |
| US9636360B2 (en) * | 2012-09-18 | 2017-05-02 | pH Science Holdings, Inc | Method and composition for treating gastro-esophageal disorders |
| US10485800B2 (en) | 2012-11-30 | 2019-11-26 | The University Of Rochester | Mixed lineage kinase inhibitors for HIV/AIDS therapies |
| US11135158B2 (en) | 2014-05-26 | 2021-10-05 | Michael Lee Martin | Medicated hard candy product for treating esophageal inflammation and a method using the same |
| US9867779B2 (en) * | 2015-03-26 | 2018-01-16 | Patheon Softgels Inc. | Liquisoft capsules |
| KR20180037994A (ko) | 2015-07-28 | 2018-04-13 | 오토노미, 인코포레이티드 | TrkB 또는 TrkC 아고니스트 조성물 및 귀 병태의 치료 방법 |
| KR102709609B1 (ko) | 2015-09-28 | 2024-09-26 | 에보니크 오퍼레이션즈 게엠베하 | 실리카계 항균성 경구용 조성물 |
| CN109689027A (zh) | 2016-06-29 | 2019-04-26 | 奥德纳米有限公司 | 甘油三酯耳用制剂及其用途 |
| SMT202500279T1 (it) | 2018-01-09 | 2025-09-12 | Dompe Farm Spa | Formulazioni del fattore di crescita auricolare |
| WO2019154895A1 (en) | 2018-02-08 | 2019-08-15 | Strekin Ag | Gel formulation for preventing or treating hearing loss |
| CA3128127A1 (en) * | 2019-03-14 | 2020-09-17 | IntraMont Technologies, Inc. | Preparations for the prevention of illnesses acquired via the oral cavity and pharynx |
| AU2021338957A1 (en) | 2020-09-08 | 2023-05-25 | Altamira Medica, Ag | Compositions for preventing infection |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3352752A (en) * | 1963-07-25 | 1967-11-14 | Tintex Corp | Intestinal adsorbent compositions |
| US4042679A (en) * | 1975-11-07 | 1977-08-16 | Colgate-Palmolive Company | Antibacterial oral composition |
| ZA831186B (en) * | 1982-03-22 | 1983-11-30 | Upjohn Ltd | Gelled pge2/triacetin solutions |
| US4427681A (en) * | 1982-09-16 | 1984-01-24 | Richardson-Vicks, Inc. | Thixotropic compositions easily convertible to pourable liquids |
| NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
| US5047244A (en) * | 1988-06-03 | 1991-09-10 | Watson Laboratories, Inc. | Mucoadhesive carrier for delivery of therapeutical agent |
| US4980175A (en) * | 1989-01-03 | 1990-12-25 | Leonard Chavkin | Liquid orally administrable compositions based on edible oils |
| US4988679A (en) * | 1989-01-03 | 1991-01-29 | Leonard Chavkin | Liquid sustained release composition |
| US5112604A (en) * | 1989-09-01 | 1992-05-12 | Riker Laboratories, Inc. | Oral suspension formulation |
| EP0452334A4 (en) * | 1989-10-31 | 1991-12-11 | Watson Laboratoires, Inc. | Mucoadhesive carrier for delivery of therapeutical agent |
| JPH0639368B2 (ja) * | 1990-02-28 | 1994-05-25 | 株式会社萩原技研 | シリカゲルを母体とした抗菌性組生物 |
| US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
| US5585115A (en) * | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
| WO1996021432A1 (en) * | 1995-01-11 | 1996-07-18 | Cygnus, Inc. | Delivery of active substances by way of mucosal surfaces of pharyngeal and esophageal regions |
| IT1275955B1 (it) * | 1995-03-22 | 1997-10-24 | Dompe Spa | Formulazioni farmaceutiche in forma di gel tissotropico |
| US5589160A (en) * | 1995-05-02 | 1996-12-31 | The Procter & Gamble Company | Dentifrice compositions |
| US5658553A (en) * | 1995-05-02 | 1997-08-19 | The Procter & Gamble Company | Dentifrice compositions |
| US6184220B1 (en) * | 1998-03-27 | 2001-02-06 | Boehringer Ingelheim Pharma Kg | Oral suspension of pharmaceutical substance |
| US20020009478A1 (en) * | 1998-08-24 | 2002-01-24 | Douglas Joseph Dobrozsi | Oral liquid mucoadhesive compositions |
-
1999
- 1999-07-27 US US09/361,542 patent/US20020009478A1/en not_active Abandoned
- 1999-08-24 CN CN99809845A patent/CN1313754A/zh active Pending
- 1999-08-24 DE DE69904057T patent/DE69904057T2/de not_active Expired - Lifetime
- 1999-08-24 AU AU55808/99A patent/AU753251B2/en not_active Ceased
- 1999-08-24 KR KR1020017001962A patent/KR20010074834A/ko not_active Ceased
- 1999-08-24 HU HU0103217A patent/HUP0103217A2/hu unknown
- 1999-08-24 ES ES99942428T patent/ES2185395T3/es not_active Expired - Lifetime
- 1999-08-24 CO CO99053435A patent/CO5140074A1/es unknown
- 1999-08-24 DK DK99942428T patent/DK1107732T3/da active
- 1999-08-24 JP JP2000565850A patent/JP2002523353A/ja not_active Withdrawn
- 1999-08-24 TR TR2001/00569T patent/TR200100569T2/xx unknown
- 1999-08-24 CA CA002338480A patent/CA2338480C/en not_active Expired - Fee Related
- 1999-08-24 BR BR9913148-0A patent/BR9913148A/pt not_active IP Right Cessation
- 1999-08-24 PE PE1999000850A patent/PE20000863A1/es not_active Application Discontinuation
- 1999-08-24 AT AT99942428T patent/ATE227978T1/de not_active IP Right Cessation
- 1999-08-24 WO PCT/US1999/019201 patent/WO2000010528A1/en not_active Ceased
- 1999-08-24 EP EP99942428A patent/EP1107732B1/de not_active Expired - Lifetime
-
2001
- 2001-02-19 NO NO20010830A patent/NO20010830D0/no not_active Application Discontinuation
- 2001-12-07 US US10/021,327 patent/US6638521B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20020076421A1 (en) | 2002-06-20 |
| WO2000010528A1 (en) | 2000-03-02 |
| DK1107732T3 (da) | 2003-03-17 |
| CN1313754A (zh) | 2001-09-19 |
| AU5580899A (en) | 2000-03-14 |
| CO5140074A1 (es) | 2002-03-22 |
| CA2338480C (en) | 2004-10-05 |
| TR200100569T2 (tr) | 2001-07-23 |
| US20020009478A1 (en) | 2002-01-24 |
| PE20000863A1 (es) | 2000-09-12 |
| KR20010074834A (ko) | 2001-08-09 |
| CA2338480A1 (en) | 2000-03-02 |
| US6638521B2 (en) | 2003-10-28 |
| NO20010830L (no) | 2001-02-19 |
| AU753251B2 (en) | 2002-10-10 |
| NO20010830D0 (no) | 2001-02-19 |
| HUP0103217A2 (hu) | 2001-12-28 |
| JP2002523353A (ja) | 2002-07-30 |
| DE69904057T2 (de) | 2003-08-21 |
| BR9913148A (pt) | 2001-09-25 |
| EP1107732A1 (de) | 2001-06-20 |
| ES2185395T3 (es) | 2003-04-16 |
| EP1107732B1 (de) | 2002-11-20 |
| DE69904057D1 (de) | 2003-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE300282T1 (de) | Orale flüssige mucoadhäsive zusammensetzungen | |
| ATE227978T1 (de) | Orale flüssige mucoadhäsive zusammensetzungen | |
| ES2303645T3 (es) | Composiciones para prevenir y tratar sintomas de tipo resfriado y gripe que comprenden cinc quelado. | |
| JPH0161086B2 (de) | ||
| CA2323680A1 (en) | Orally disintegrable tablets | |
| JPH03197430A (ja) | 呼吸器管感染症用スプレー剤 | |
| CA2321819A1 (en) | Xylitol compositions for treating upper respiratory conditions | |
| CA2277365A1 (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 | |
| FR2712807B1 (fr) | Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale . | |
| WO2003015746A1 (en) | Nasal passage cleaning composition | |
| WO2003101434A3 (en) | Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor | |
| DK1107734T3 (da) | Orale væskeformige mucoadhæsive sammensætninger | |
| WO2001012128A3 (en) | Antibacterial agents for the treatment of acute mucosal infections | |
| JP2001139465A (ja) | 咽頭粘膜用組成物 | |
| JP2002145764A (ja) | 咽頭粘膜用組成物 | |
| GB2243548A (en) | Therapeutic nasal drops containing sulphonamides | |
| JP2007022971A (ja) | 経鼻投与のための組成物 | |
| BR0205625C1 (pt) | Formulações nasais em gel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |